The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial

D Da Xu (Chongqing Key Laboratory of Natural Product Synthesis and Drug Research, School of Pharmaceutical Sciences) H Hongwei Wang (School of Physics and Laboratory of Zhongyuan Light) Q Quan Bao K Kemin Jin M Ming Liu W Wei Liu X Xiaoluan Yan L Lijun Wang Y Yanqiao Zhang G Guangyu Wang Y Yue Ma Z Zhigang Ma C Chunhui Zhang (Key Laboratory of Bioinorganic and Synthetic Chemistry of Ministry of Education, School of Chemistry, and Guangdong Key Laboratory of Chiral Molecule and Drug Discovery) J Jiebing Tang S Sha Wang J Jiaohui Pang T Ting Xu K Kun Wang (Beijing National Laboratory for Molecular Science, State Key Laboratory of Rare Earth Materials Chemistry and Applications, College of Chemistry and Molecular Engineering) B Baocai Xing